Fanapanel
id:
fanapanel-289-8717204
title:
Fanapanel
text:
Fanapanel, also known as MPQX, is a quinoxalinedione derivative drug which acts as a competitive antagonist of the AMPA receptor. It was under development by Schering AG for the treatment of cerebral ischemia associated with stroke and trauma, but clinical trials were halted for safety reasons related to possible glial cell toxicity and due to intolerable side effects such as excessive sedation, reduction in consciousness, and transient neurological deterioration. The drug was also observed to p
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Fanapanel
date created:
date modified:
2023-08-18T04:43:11Z
main entity:
{"identifier":"Q19597235","url":"https://www.wikidata.org/entity/Q19597235"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b6/Fanapanel.svg","width":1050,"height":940}
fields total:
13
integrity:
15